The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2442821
WO Application Number:
US2010038663
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10790053.2
WO Publication Number:
WO2010147981
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
15/06/2010
Grant date:
14/06/2017
EP Publication Date:
25/04/2012
WO Publication Date:
23/12/2010
Claims Translations Received Date:
Claims Translation B1 Received Date:
29/08/2017
Claims Translation B2 Received Date:
12/05/2025
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/06/2017
EP B1 Publication Date:
14/06/2017
EP B2 Publication Date:
12/02/2025
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/06/2030
Lapsed By Expiration Date:
Patent Validated Date:
17/05/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
28/05/2025
Name:
Acerus Pharmaceuticals USA, LLC
Address:
500 Office Center Drive
Suite 400, 19034, Fort Washington, PA, United States of America (US)
Historical Applicant/holder
From:
20/10/2017
To:
28/05/2025
Name:
Serenity Pharmaceuticals LLC
Address:
105 Hawk Court, 18337, Milford, PA, United States of America (US)
From:
14/06/2017
To:
20/10/2017
Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, IRVINE, CA 92612, United States of America (US)
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
3
Bulletin Heading:
MED
Journal edition number:
07/25
Publication date:
12/02/2025
Description:
Other communications
4
Bulletin Heading:
EP4
Journal edition number:
07/25
Publication date:
12/02/2025
Description:
European patents granted in amended form for the Netherlands
5
Bulletin Heading:
VB2
Journal edition number:
07/23
Publication date:
15/02/2023
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995 in respect of which a decision has been taken. Opposition(s) decisions ex European Patent Convention
6
Bulletin Heading:
CO
Journal edition number:
49/17
Publication date:
06/12/2017
Description:
Changes in the Netherlands Patent Register
7
Bulletin Heading:
EP3
Journal edition number:
37/17
Publication date:
13/09/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
8
Bulletin Heading:
EP2
Journal edition number:
24/17
Publication date:
14/06/2017
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202507
Publication date:
12/02/2025
Description:
Patent maintained (B2 publication)
2
Issue number:
202347
Publication date:
22/11/2023
Description:
International Patent Classification Changed
3
Issue number:
202307
Publication date:
15/02/2023
Description:
Opposition Withdrawn
4
Issue number:
201724
Publication date:
14/06/2017
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202500975A
Date Registered:
28/05/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. A. Blokland c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Acerus Pharmaceuticals USA, LLC
Address:
500 Office Center Drive
Suite 400, 19034, Fort Washington, PA, United States of America (US)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201702068A
Date Registered:
20/10/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
drs. C.M.A. Quintelier
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Serenity Pharmaceuticals LLC
Address:
105 Hawk Court, 18337, Milford, PA, United States of America (US)